Skip to main content

Bulldog Bio, Nippon Genetics Europe Reach Product Sales Deal for US

NEW YORK (GenomeWeb News) – Bulldog Bio will have the exclusive rights to sell many of Nippon Genetics Europe's electrophoresis and cell biology products to researchers in the US under an agreement announced today.

Bulldog Bio, in return, will support, market, and stock Nippon Genetics Europe's products.

Nippon Genetics Europe, based in Düren, Germany, is a subsidiary of Nippon Genetics focused on distributing cell biology, genomics, and proteomics products. Portsmouth, N.H.-based Bulldog Bio distributes tools to life science researchers.

Financial and other terms were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.